Premier Biomedical, Inc.
BIEI
$0.0004
-$0.0002-33.33%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Net Income | 93.16% | 50.04% | -127.00% | -87.90% | 44.78% |
| Total Depreciation and Amortization | 16.67% | 33.33% | 16.67% | 0.00% | 20.00% |
| Total Amortization of Deferred Charges | 333.39% | -75.57% | -80.38% | -95.24% | -61.58% |
| Total Other Non-Cash Items | -201.99% | -37.40% | 318.27% | 77.41% | -43.72% |
| Change in Net Operating Assets | 255.21% | 43.64% | 77.61% | 84.00% | -122.11% |
| Cash from Operations | 43.83% | 22.74% | 16.91% | -8.48% | 7.47% |
| Capital Expenditure | -- | -- | -- | -40.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -40.00% | -- |
| Total Debt Issued | -- | -28.67% | 91.67% | 8.33% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -83.33% | -28.67% | 91.67% | 8.33% | 24.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -294.92% | -42.91% | 108.42% | -24.44% | 225.53% |
